V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20210769 | 20128341 | 1.55 | 78.4 | Palliative (P) | 2016-07-02 | 2016-07-03 | ECX | 02 | N | ECX | 100790938 |
| 20210782 | 20128343 | 1.82 | 50 | Palliative (P) | 2019-10-08 | 2019-10-08 | Carboplatin + Etoposide IV 3 day | 02 | N | CARBOPLATIN + ETOPOSIDE | 101092898 |
| 20210786 | 20128344 | 1.67 | 52 | Curative (C) | 2017-09-28 | 2017-09-29 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100365847 |
| 20210787 | 20128345 | 1.56 | null | Neo-adjuvant (N) | 2019-11-30 | 2021-11-01 | Carboplatin + Etoposide iv&po | 02 | N | CARBOPLATIN + ETOPOSIDE | 100180458 |
| 20210792 | 20128346 | 1.53 | 60.3 | null | 2019-11-09 | 2019-11-24 | ECX | 02 | null | ECX | 100393674 |
| 20210796 | 20128347 | 1.78 | 92.48 | null | 2017-09-02 | 2017-09-04 | ECX | 2 | Y | ECX | 100562021 |
| 20210800 | 20128348 | 1.78 | null | Neo-adjuvant (N) | 2017-03-17 | 2017-03-30 | null | 02 | Y | ECX | 100506056 |
| 20210806 | 20128349 | 1.78 | 91.35 | null | 2020-04-27 | 2020-05-11 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 100634991 |
| 20210811 | 20128350 | 1.6 | 118.7 | Palliative (P) | 2016-04-24 | 2016-07-16 | NIVOLUMAB | null | null | NIVOLUMAB | 100362822 |
| 20210814 | 20128351 | 1.84 | 59.6 | null | 2018-09-06 | 2018-09-06 | null | 02 | N | PANITUMUMAB | 100254617 |
| 20210821 | 20128352 | null | 74.3 | Palliative (P) | 2018-05-09 | 2018-05-30 | null | 02 | Y | CISPLATIN + FLUOROURACIL | 101226094 |
| 20210827 | 20128353 | 1.75 | null | Palliative (P) | null | 2018-11-27 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101519295 |
| 20210830 | 20128354 | 1.67 | 88 | Neo-adjuvant (N) | 2018-09-21 | 2018-09-21 | Panitumumab | 02 | N | PANITUMUMAB | 101709402 |
| 20210833 | 20128355 | 1.62 | 92.5 | null | 2018-08-20 | 2018-09-16 | NIVOLUMAB | null | null | NIVOLUMAB | 100698632 |
| 20210842 | 20128356 | 1.7 | 57.6 | null | 2018-08-11 | 2018-08-26 | null | 02 | null | PANITUMUMAB | 101157678 |
| 20210843 | 20128357 | 1.6 | null | Adjuvant (A) | 2020-10-30 | 2020-12-18 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101780499 |
| 20210850 | 20128358 | 1.78 | 61.8 | 03 | null | 2019-12-22 | ECX | 02 | null | ECX | 101769816 |
| 20210852 | 20128359 | 1.52 | 88.5 | Curative (C) | 2018-05-20 | 2018-05-24 | NIVOLUMAB | null | null | NIVOLUMAB | 100429287 |
| 20210857 | 20128360 | 1.57 | 70.5 | Palliative (P) | 2018-03-10 | 2018-04-27 | null | 02 | N | PANITUMUMAB | 100623249 |
| 20210868 | 20128362 | 1.72 | 59.2 | Palliative (P) | 2017-04-13 | 2017-04-13 | ECX | 2 | N | ECX | 101553044 |
| 20210877 | 20128363 | 1.67 | 59.95 | Neo-adjuvant (N) | 2019-02-06 | 2019-03-27 | Panitumumab | 02 | null | PANITUMUMAB | 100813452 |
| 20210879 | 20128364 | 1.7 | 46.6 | Palliative (P) | 2019-11-13 | 2019-12-03 | null | 02 | N | PANITUMUMAB | 100880388 |
| 20210898 | 20128366 | null | 66.75 | Neo-adjuvant (N) | null | 2019-04-26 | null | 02 | N | PANITUMUMAB | 101528039 |
| 20210912 | 20128367 | 1.7 | 72.4 | Adjuvant (A) | 2019-10-14 | 2020-02-02 | null | N | N | PANITUMUMAB | 101833695 |
| 20210917 | 20128368 | 1.77 | 103.1 | null | null | 2020-02-02 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100608586 |
| 20210926 | 20128369 | null | null | null | 2017-11-13 | 2017-12-03 | null | 2 | null | PANITUMUMAB | 100795957 |
| 20210930 | 20128370 | 1.6 | 77.5 | null | 2016-05-30 | 2016-06-07 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101413441 |
| 20210936 | 20128371 | 1.7 | 65.7 | Palliative (P) | null | 2019-04-18 | null | 2 | N | PANITUMUMAB | 100319216 |
| 20210938 | 20128372 | 1.58 | 69 | Palliative (P) | 2018-02-25 | 2018-03-01 | null | N | N | PANITUMUMAB | 101365603 |
| 20210943 | 20128373 | null | null | Palliative (P) | 2019-01-07 | 2019-01-15 | ECX | N | N | ECX | 101384900 |
| 20210945 | 20128374 | 1.51 | 48.25 | Neo-adjuvant (N) | 2016-08-14 | 2017-08-07 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101554597 |
| 20210957 | 20128375 | 1.8 | 90 | null | 2017-02-21 | 2017-03-14 | ECX | 2 | null | ECX | 100506769 |
| 20210962 | 20128376 | 1.8 | 54.2 | Adjuvant (A) | null | 2018-09-15 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100679070 |
| 20210967 | 20128377 | 1.77 | 75.3 | Neo-adjuvant (N) | 2018-08-29 | 2018-09-24 | ECX | N | null | ECX | 100146799 |
| 20210979 | 20128378 | 1.77 | 83.8 | null | 2019-09-30 | 2020-08-29 | ECX | null | null | ECX | 101684552 |
| 20210996 | 20128380 | 1.67 | 82 | null | 2019-11-03 | 2020-01-10 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101222269 |
| 20210997 | 20128381 | 1.83 | 75.6 | null | 2018-04-18 | 2018-04-20 | ECX | 2 | null | ECX | 100271069 |
| 20210999 | 20128382 | 1.76 | 125 | null | null | 2017-06-23 | null | 02 | null | CISPLATIN + FLUOROURACIL | 100573211 |
| 20211004 | 20128383 | 1.75 | 75 | Palliative (P) | 2020-01-03 | 2020-01-24 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100010523 |
| 20211005 | 20128384 | 1.77 | 68.6 | null | null | 2018-01-14 | Panitumumab | 02 | null | PANITUMUMAB | 101136575 |
| 20211006 | 20128385 | 1.65 | 84.6 | Palliative (P) | 2021-10-29 | 2022-01-02 | ECX | null | N | ECX | 101794602 |
| 20211029 | 20128386 | 1.54 | 90.35 | null | 2019-09-18 | 2019-09-22 | null | 02 | Y | CARBOPLATIN + ETOPOSIDE | 100425386 |
| 20211031 | 20128387 | 1.61 | 59.7 | null | 2021-12-17 | 2021-12-23 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101605895 |
| 20211041 | 20128389 | 1.7 | 89 | null | null | 2019-11-22 | Panitumumab | N | null | PANITUMUMAB | 101819901 |
| 20211042 | 20128390 | 1.63 | 82.2 | null | null | 2019-09-21 | ECX | 02 | null | CARBOPLATIN + ETOPOSIDE | 101797242 |
| 20211045 | 20128391 | 1.75 | 52.2 | null | 2016-05-06 | 2016-05-14 | null | 02 | null | CISPLATIN + FLUOROURACIL | 101150274 |
| 20211048 | 20128392 | 1.7 | 48.25 | Palliative (P) | 2021-08-11 | 2021-08-23 | Panitumumab | 2 | N | PANITUMUMAB | 101722776 |
| 20211058 | 20128393 | 1.82 | null | Neo-adjuvant (N) | 2020-10-02 | 2020-10-03 | null | 02 | Y | CISPLATIN + FLUOROURACIL | 101618383 |
| 20211060 | 20128394 | 1.6 | 62.8 | null | 2021-01-09 | 2021-01-11 | Carboplatin + Etoposide iv&po | N | null | CARBOPLATIN + ETOPOSIDE | 101236585 |
| 20211062 | 20128395 | 1.64 | 64.3 | Palliative (P) | 2019-04-08 | 2019-06-19 | Carboplatin + Etoposide IV 3 day | 02 | N | CARBOPLATIN + ETOPOSIDE | 100301124 |